ALVO
Price:
$11.08
Market Cap:
$3.34B
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to t...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-06-16
Stock Exchange
NASDAQ
Ticker
ALVO
According to Alvotech’s latest financial reports and current stock price. The company's current PE Ratio is -4.18. This represents a change of -630.36% compared to the average of 0.79 of the last 4 quarters.
The mean historical PE Ratio of Alvotech over the last ten years is -5.41. The current -4.18 PE Ratio has changed 7.62% with respect to the historical average. Over the past ten years (40 quarters), ALVO's PE Ratio was at its highest in in the June 2024 quarter at 13.24. The PE Ratio was at its lowest in in the June 2021 quarter at -387.36.
Average
-5.41
Median
-3.85
Minimum
-12.99
Maximum
-2.06
Discovering the peaks and valleys of Alvotech PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 67.52%
Maximum Annual PE Ratio = -2.06
Minimum Annual Increase = -84.17%
Minimum Annual PE Ratio = -12.99
Year | PE Ratio | Change |
---|---|---|
2023 | -4.73 | 22.82% |
2022 | -3.85 | 11.75% |
2021 | -3.45 | 67.52% |
2020 | -2.06 | -84.17% |
The current PE Ratio of Alvotech (ALVO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.01
5-year avg
-5.41
10-year avg
-5.41
Alvotech’s PE Ratio is less than Intra-Cellular Therapies, Inc. (0), greater than Catalent, Inc. (-90.48), greater than Amphastar Pharmaceuticals, Inc. (-10.87), less than Assertio Holdings, Inc. (13.33), less than ANI Pharmaceuticals, Inc. (-0.35), less than Alkermes plc (43.28), less than Dr. Reddy's Laboratories Limited (15.66), less than Collegium Pharmaceutical, Inc. (19.95), less than Pacira BioSciences, Inc. (12.07), less than Cyclo Therapeutics, Inc. (10.06), less than Athenex, Inc. (-0.94), less than MedMen Enterprises Inc. (-0.03), less than Lifecore Biomedical, Inc. (-0.00), less than Lucy Scientific Discovery Inc. (12.14), less than null (-0.72),
Company | PE Ratio | Market cap |
---|---|---|
0 | $7.77B | |
-90.48 | $10.86B | |
-10.87 | $2.21B | |
13.33 | $120.12M | |
-0.35 | $1.27B | |
43.28 | $4.42B | |
15.66 | $13.19B | |
19.95 | $1.20B | |
12.07 | $638.86M | |
10.06 | $19.51M | |
-0.94 | $2.33M | |
-0.03 | $138.32K | |
-0.00 | $147.38M | |
12.14 | $906.91K | |
-0.72 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alvotech using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alvotech or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Alvotech's PE Ratio?
How is the PE Ratio calculated for Alvotech (ALVO)?
What is the highest PE Ratio for Alvotech (ALVO)?
What is the 3-year average PE Ratio for Alvotech (ALVO)?
What is the 5-year average PE Ratio for Alvotech (ALVO)?
How does the current PE Ratio for Alvotech (ALVO) compare to its historical average?